홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphate → N-cyclobutyl-6-[2-(4-cyclobutylpiperazin-1-yl)-2-oxoethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine-2-carboxamide

HRID 1713133
인쇄

반응식

HRID 1713133 반응식
Cl.[CH:2]1([NH:6][C:7]([C:9]2[CH:18]=[CH:17][C:16]3[CH2:15][N:14]([CH2:19][C:20]([OH:22])=O)[CH2:13][CH2:12][C:11]=3[N:10]=2)=[O:8])[CH2:5][CH2:4][CH2:3]1.[CH:23]1([N:27]2[CH2:32][CH2:31][NH:30][CH2:29][CH2:28]2)[CH2:26][CH2:25][CH2:24]1.F[P-](F)(F)(F)(F)F.N1(O[P+](N(C)C)(N(C)C)N(C)C)C2C=CC=CC=2N=N1>C(Cl)Cl>[CH:2]1([NH:6][C:7]([C:9]2[CH:18]=[CH:17][C:16]3[CH2:15][N:14]([CH2:19][C:20]([N:30]4[CH2:31][CH2:32][N:27]([CH:23]5[CH2:26][CH2:25][CH2:24]5)[CH2:28][CH2:29]4)=[O:22])[CH2:13][CH2:12][C:11]=3[N:10]=2)=[O:8])[CH2:3][CH2:4][CH2:5]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 151348Benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphateHCID 47386021-CyclobutylpiperazineHCID 66877729{2-[(cyclobutylamino)carbonyl]-7,8-dihydro-1,6-naphthyridin-6(5H)-yl}acetic acid hydrochloride

생성물 1

HCID 59463539N-cyclobutyl-6-[2-(4-cyclobutylpiperazin-1-yl)-2-oxoethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine-2-carboxamide

시약·촉매·용매 1

HCID 6344
Dichloromethane
용매

실험 절차

A mixture of {2-[(cyclobutylamino)carbonyl]-7,8-dihydro-1,6-naphthyridin-6(5H)-yl}acetic acid hydrochloride (37 mg, 0.11 mmol), 1-cyclobutylpiperazine (19 mg, 0.133 mmol), BOP (59 mg, 0.133 mmol) and TEA (0.075 ml, 0.532 mmol) in DCM (5 ml) is stirred at rt overnight. The solvent is removed in vacuo and the residue is partitioned between water (10 mL) and EtOAc (10 mL). The layers are separated and the aqueous layer is extracted with EtOAc (10 ml). The combined extracts are washed with brine (10 mL), dried and evaporated. The residue is purified by PTLC to give the title compound as a light yellow oil. MS (M+1): 412.4; 1H NMR (δ, CDCl3): 8.11 (d, 1H), 7.94 (d, 1H), 7.43 (d, 1H), 4.53-4.61 (m, 1H), 3.75 (s, 2H), 3.58-3.66 (m, 4H), 3.45 (t, 2H), 3.40 (s, 2H), 3.04 (t, 2H), 2.92 (t, 2H), 2.63-2.76 (m, 1H), 2.36-2.46 (m, 2H), 2.25-2.32 (m, 6H), 1.63-2.06 (m, 6H).

후처리

  1. customThe solvent is removed in vacuo
  2. customthe residue is partitioned between water (10 mL) and EtOAc (10 mL)
  3. customThe layers are separated
  4. extractionthe aqueous layer is extracted with EtOAc (10 ml)
  5. washThe combined extracts are washed with brine (10 mL)
  6. customdried
  7. customevaporated
  8. customThe residue is purified by PTLC

출처 및 근거

ORD 기록
ord-2dc04d11e7f94256ac76cb3ec97dd594
출처 데이터셋
uspto-grants-2010_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07795262B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트